Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VIRO-IMMUN Labor-Diagnostika is a specialized German medical diagnostics company that develops and manufactures high-quality in vitro diagnostic (IVD) test systems. The company's portfolio primarily focuses on serological assays for the detection of infectious diseases caused by viruses, bacteria, and parasites, as well as solutions for autoimmune diagnostics. Their product lines include Enzyme-Linked Immunosorbent Assays (ELISA), Line Immunoblots, and Indirect Immunofluorescence Assays (IFA). In 2017, the company was acquired by Eurofins Scientific and now operates within the Eurofins Gold Standard Diagnostics division. Based in Oberursel, VIRO-IMMUN provides laboratory solutions used globally for the precise identification of pathogen-specific antibodies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VIRO-IMMUN.